Therapeutic approaches to Type 2 diabetes mellitus

Author： Rose M.L. Paulik M.A. Lenhard J.M.

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.9, 1999-09, pp. : 1223-1236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repaglinide: A Review of its Therapeutic Use in Type 2 Diabetes Mellitus

By Culy C.R. Jarvis B.

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1625-1660

Adis International

Access to resources Recommend Favorite

Miglitol: A Review of its Therapeutic Potential in Type 2 Diabetes Mellitus

By Scott L.J. Spencer C.M.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 521-549

Adis International

Access to resources Recommend Favorite

Resistin: A Promising Therapeutic Target for the Management of Type 2 Diabetes Mellitus?

Drug Design Reviews - Online, Vol. 2, Iss. 1, 2005-02 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite

DGAT: Novel Therapeutic Target for Obesity and Type 2 Diabetes Mellitus

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 263-270

Bentham Science Publishers

Access to resources Recommend Favorite

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite